Preprint
via Europe PMC
Magnesium and Rapamycin in Long Covid and Longevity: A Mechanistic and Therapeutic Approach
· 2026
Abstract
A global shortfall in magnesium (Mg) is linked to long Covid and a shortened lifespan. Calcium (Ca) competes with Mg for the same receptor and the West ingests too much calcium and the East too little. An intake of Ca:Mg (weight to weight) close to 2:1 has been promulgated as the best measure of balance, but on a Western diet 3:2 might be a better target. RBC Mg sits at the nexus of intracellular Mg and serum Mg. This enables easy determination of serum Ca:Mg that reflects the intake ratio and general health status. Nutrient sensitive mTOR(definition) (mammalian target of rapamycin(definition)) and energy sensitive AMPK are inversely related. A balanced mTOR:AMPK ratio, is linked to healthy aging. Multiple studies in yeast, worms, flies, and rodents support the efficacy of rapamycin as a longevity agent. Any inhibition of mTOR by rapamycin can upregulate kinases that activate mTOR via alternate pathways. Whether this occurs with low-dose, intermittent rapamycin is unknown. But Mg is perfectly placed to block this. Rapamycin is a top down longevity agent, while Mg empowers longevity from the bottom up. They collaborate without competing. Efficacies may merge at the IFN-γ, indoleamine dioxygenase (IDO), kynurenine, aryl hydrocarbon receptor (AhR) interface. Persistence of any intracellular pathogen, e.g., SARS CoV2, can prolong IFN-γ activation of IDO. IDO metabolizes tryptophan (T) and upregulates the kynurenine (K) pathway, leaving less T for the indole (longevity biomarker) and serotonin pathways. An elevated K/T is linked to cancer, autoimmune disease, cardiovascular disease, dementia, diabetes, obesity, and chronic inflammation in general. Furthermore, Mg-dependent vitamin D immunomodulates IFN-γ.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.32388/u5jtwn
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
P., C. (2026). Magnesium and Rapamycin in Long Covid and Longevity: A Mechanistic and Therapeutic Approach. https://doi.org/10.32388/u5jtwn
Vancouver
P. C. Magnesium and Rapamycin in Long Covid and Longevity: A Mechanistic and Therapeutic Approach. 2026. doi:10.32388/u5jtwn.
BibTeX
@unpublished{chambers2026Magnes,
title = {Magnesium and Rapamycin in Long Covid and Longevity: A Mechanistic and Therapeutic Approach},
author = {Chambers P.},
year = {2026},
doi = {10.32388/u5jtwn},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Qeios 2026
Preprint · CC-BY
Magnesium and Rapamycin in Long Covid and Longevity: A Mechanistic and Therapeutic Approach
Qeios 2026
Preprint · CC-BY
Magnesium and Rapamycin in Long Covid and Longevity: A Mechanistic and Therapeutic Approach
Qeios 2026
Preprint · CC-BY
Magnesium and Rapamycin in Long Covid and Longevity: Mechanistic (Part A) and Therapeutic (Part B) Proposals
Journal of Biological Chemistry 2013
Open access · CC-BY
Redox Control of the Senescence Regulator Interleukin-1α and the Secretory Phenotype
Molecular Neurodegeneration 2021
Open access · CC-BY
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Drugs in R&D 2015
Open access · CC-BY